Latest News

Immune-modulating drug unexpectedly benefits mice with fatal mitochondrial defect

In a lab devoted to increasing healthy lifespans, the transplant anti-rejection drug rapamycin showed unexpected health benefits and increased survival in a mouse model of a fatal mitochondrial defect. Children with the untreatable condition suffer from brain damage and muscle weakness, and rarely live beyond 6 or 7 years. The drug enables the body to bypass the mitochondrial defect by switching its metabolism to burn fats and amino acids instead of glucose, and thereby reduces toxic byproducts.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Genetic dysfunction connected to hydrocephalus discovered by international research team

  • Good news for aging population: Incidence of stroke in elderly has dropped by 40% over last 20 years

  • You should talk to strangers: Doing so increases positive experience, study shows

  • High rates of violence suffered by unstably housed women in San Francisco

  • Mothers of Children with Autism Benefit From Peer-Led Intervention

  • Children's impulsive behaviour is related to brain connectivity

  • Innovative system anticipates driver fatigue in the vehicle to prevent accidents

  • Rigid connections: Molecular basis of age-related memory loss explained

  • Low strength brain stimulation may be effective for depression

  • High school lacrosse players at risk for concussions, other injuries, study finds

  •